Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

Anthem Blue Cross Blue Shield and Memorial Sloan Kettering Cancer Center have reached a deal that keeps the premiere cancer ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

Tests from Castle Biosciences, Pacific Edge Diagnostics, Interpace Biosciences, Clinical Genomics, and the University of Pittsburgh Medical Center will no longer be covered.